Globe Life (GL) EVP Michael Clay Majors Sells $2.2M of Stock

Key Points

  • Michael Clay Majors, the Chief Strategy Officer at Globe Life, sold 14,377 shares at an average price of $154.48, totaling approximately $2.22 million.
  • After this sale, Majors holds 39,141 shares, cutting his stake by about 26.9%.
  • The stock recently traded around $157.90, which is about 2% above the closing price of $154.79 on the day of the sale.

Since the trade, $GL is up 2.3% to date (from the $154.79 close on Oct 23, 2026).

Get Globe Life text alerts

We text you when insiders, Congress, analysts or big funds move on $GL.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures

Michael Clay Majors, the Chief Strategy Officer at Globe Life Inc. (GL), sold 14,377 shares on October 23, 2026, for about $2.22 million. This transaction was reported in a Form 4 filing with the SEC. Majors' sale reduces his ownership by about 26.9%, leaving him with 39,141 shares.

GL Globe Life Inc.
$158.31 +15.30% year to date
Daily close · Oct 26, 2026

What Changed in Globe Life's Position

Majors sold his shares at an average price of $154.48, which was the price on the day of the sale. This sale indicates a significant reduction in his stake, which may reflect his views on the company's current valuation or future prospects.

Other Institutional Activity in Globe Life

Pzena Investment Management increased its holdings by 50,199 shares, bringing its total to 1,026,246 shares valued at about $183.4 million. AQR Capital Management, LLC raised its stake by 318,052 shares, totaling 1,515,987 shares worth approximately $237.7 million. Meanwhile, Nuveen, LLC slightly decreased its position by 2,248 shares, ending with 1,496,640 shares valued at about $234.7 million.

Globe Life Inc. Stock Down 6.2%

As of October 26, 2026, Globe Life shares were recently trading around $157.90, which is about 2% above the closing price of $154.79 on October 23, 2026. The stock is currently about 17.6% below its 52-week high of $191.55 and 23.5% above its 52-week low of $127.85. This indicates that the stock has some room to recover but is not performing at its peak.

Recent Earnings

In its latest earnings report, Globe Life reported a trailing twelve-month revenue of approximately $6.27 billion and an EPS of $14.94. The next earnings report is expected on February 3, 2027.

Insider Buying and Selling at Globe Life Inc.

Since June, several insiders have made trades. Rebecca Zorn, EVP & Chief Talent Officer, sold 2,000 shares at no price reported. She also bought 2,000 shares at $98.32 on June 18, 2026. Dolores Skarjune, EVP and Chief Admin. Officer, sold 1,850 shares at $179.18 on June 30, 2026, after buying 1,850 shares earlier for $103.23.

Analysts Set New Price Targets

On October 23, 2026, Piper Sandler downgraded Globe Life to Neutral with a new price target of $165, down from $200. Evercore ISI Group maintained its In-Line rating with a target of $174, while TD Cowen maintained its Buy rating but lowered the target to $215 from $225. JP Morgan kept its Overweight rating with a target of $195.

About Globe Life

Globe Life Inc. offers life and supplemental health insurance products primarily to lower middle- and middle-income families in the U.S. The company operates in three main segments: Life Insurance, Supplemental Health Insurance, and Investments. The recent insider transaction might suggest a shift in sentiment among executives as the company navigates its market position.

Bottom Line

Investors should watch for Globe Life's next earnings release on February 3, 2027, and keep an eye on further insider transactions and analyst ratings for insights into the company's performance.

Source: Michael Clay Majors's Form 4 filing on $GL (Oct 23, 2026). Written by software, not financial advice. How we make alerts

Get $GL trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions